GE HealthCare Technologies Inc (NAS:GEHC)
$ 64.7 (0%) Market Cap: 29.43 Bil Enterprise Value: 37.98 Bil PE Ratio: 15.48 PB Ratio: 2.76 GF Score: 72/100

Q2 2024 GE Healthcare Technologies Inc Earnings Call Transcript

Jul 31, 2024 / 12:30PM GMT
Release Date Price: $84.63 (+2.40%)

Key Points

Positve
  • Delivered 1% organic revenue and 3% orders growth with all segments contributing.
  • Expanded margins despite headwinds in the China market.
  • Strong performance in the US market, particularly in imaging, IGT, and ultrasound.
  • Raised adjusted EBIT margin guidance due to productivity and optimization initiatives.
  • Secured more than $800 million in multimodality equipment, software, and service contracts in the US.
Negative
  • Lowered full-year organic revenue growth guidance due to prolonged timing of the China stimulus rollout.
  • Anticipated continued sales decline in China for the second half of the year.
  • Negative free cash flow in the second quarter due to timing of certain payments.
  • Organic revenue in the ultrasound segment was down 1% year over year, primarily due to China market headwinds.
  • Patient care solutions segment EBIT margin decreased 90 basis points year over year due to product mix.
Operator

Good day, everyone, and thank you for standing by. Welcome to GE Healthcare's second-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I will hand the call over to the Chief Investor Relations Officer, Carolynne Borders. You may begin.

Carolynne Borders
GE Healthcare Technologies Inc - IR

Thanks, operator. Good morning, and welcome to GE Healthcare's second-quarter 2024 earnings call. I'm joined by our President and CEO, Peter Arduini; and Vice President and CFO, Jay Saccaro.

Our conference call remarks will include both GAAP and non-GAAP financial results. Reconciliations between GAAP and non-GAAP measures can be found in today's press release and in the presentation slides available on our website.

During this call, we'll make forward-looking statements about our performance. These statements are based on how we see things today. As described in our SEC filings, actual results may differ materially due to risks and uncertainties. And with that, I'll hand the call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot